maaf email atau password anda salah

Overcoming the Valley of Death

Monday, March 15, 2021

The Research and Innovation Consortium for the Acceleration of Covid-19 Mitigation developed 50 products. Government institutions involved in handling the pandemic are less enthusiastic in adopting these innovations.

arsip tempo : 172864524843.

A researcher conducting testing in connection with the production of a SARS-CoV-2 vaccine, at a Bio Farma research lab in Bandung, West Java, last August. Tempo/Prima Mulia . tempo : 172864524843.

EIGHT products of the Research and Innovation Consortium for the Acceleration of Covid-19 Mitigation were displayed on stage in the Auditorium of B.J. Habibie Building, at the research and technology ministry, Jakarta, Tuesday, March 2. That day marked the one-year of the Covid-19 pandemic in Indonesia. Research and Technology Minister/National Research and Innovation Agency Head Bambang Brodjonegoro said that one of the consortium’s main ac

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • October 7, 2024

  • September 30, 2024

  • September 23, 2024

  • September 16, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe